Idelalisib Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Idelalisib Tablet (tablet) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on Apr 7, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Gilead Sciences, Inc.
- Package NDC
- 61958-1701-1
- Dosage Form
- Tablet
- Presentation
- Zydelig, Tablet, 100 mg (NDC 61958-1701-1)
- Initial Posting
- Apr 7, 2026